期刊文献+

女性假两性畸形诊断和治疗 被引量:1

Diagnosis and treatment of female pseudohermaphroditism
原文传递
导出
摘要 目的探讨女性假两性畸形的病因、临床特点、诊断和治疗措施。方法收集5例女性假两性畸形患者的临床资料,对其病因、临床特点、诊断和治疗进行讨论。结果5例患者,诊断为外源性雄激素引起的女性假两性畸形1例,先天性肾上腺皮质增生引起的女性假两性畸形4例。均外阴发育异常,染色体核型为46XX。5例行保留阴蒂头及其血管神经蒂阴蒂成形术,4例术后予氢化可的松替代治疗,3个月后促肾上腺皮质激素、睾酮均降至正常。5例随访1~10年,外生殖器外观满意,阴蒂头血运、感觉良好,第二性征明显女性化,3例已基本上转变性别角色,2例尚存在不同程度的心理障碍。结论女性假两性畸形患者应尽早诊断,早期予糖皮质激素替代治疗,早期行阴蒂短缩术,以减轻患者心理负担,提高生活质量。 Objective To discuss the etiology, clinical features, diagnosis and treatment measures of female pseudohermaphroditism. Methods Five cases of female pseudohermaphroditism were collected. The etiology, clinical features, diagnosis and treatment measures were discussed. Results One case induced by exogenous androgenic hormones,4 cases induced by congenital adrenal hyperplasia. All the 5 cases presented with abnormal development of vulva and the sex chromosomes karyotype of 46XX. The combined treatment of reconstructive surgery (5 cases) and supplementary glucocorticoid (4 cases) were performed. After 3 months,the levels of adrenocorticotrophic hormone and virosterone were normal. Followed up for 1-10 years, The postoperative appearance of external genitalia was similar to the normal. The secondary sex characters were improved obviously, 3 cases were mainly feminilism, 2 cases existed different degree of psychologic obstacle. Conclusions The diagnosis and treatment in the early stage are very important. The combination treatment of surgery and medicine for the patients with female pseudohermaphroditism is satisfied.
出处 《中国医师进修杂志》 2010年第12期8-10,共3页 Chinese Journal of Postgraduates of Medicine
关键词 女(雌)性 假两性畸形 肾上腺增生 先天性 诊断 治疗 Female Pseudohermaphroditism Adrenal hyperplasia,congenital Diagnosis Therapy
  • 相关文献

参考文献13

  • 1Wisniewski AB,Migeon C J, Malouf MA,et al. Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol,2004,171 (6 Pt 1):2497- 2501.
  • 2罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 3王家娜,刘惠莲.21-羟化酶缺乏症16例[J].华西医学,2005,20(2):361-361. 被引量:10
  • 4Baumgartner-Parzer SM,Fischer G,Vierhapper H. Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene. J Clin Endocrinol Metab,2007,92 (3):1164-1167.
  • 5Moran C,Azziz R,Weintrob N,et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab, 2006,91 (9) : 3451-3456.
  • 6刘毅,王养民,苏志红,张诚,张鲜英,钟晓玲.女性假两性畸形的手术治疗[J].实用美容整形外科杂志,2003,14(5):254-255. 被引量:13
  • 7Aycan Z, Ocal G, Berberoglu M, et al. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential. J Pediatr Endocrinol Metab, 2006,19 (3) : 245-251.
  • 8Khadilkar VV, Khadilkar AV, Maskati GB. Impact of availability of oral hydrocortisone on growth of children with CAH. Indian J Pediatr, 2005,72(4) : 301-303.
  • 9孙文鑫.先天性肾上腺皮质增生症的长期治疗及疗效评价[J].实用儿科临床杂志,2009,24(8):569-571. 被引量:7
  • 10廖二元,超楚生主编.内分泌学.北京:人民卫生出版社,2006.921,934.

二级参考文献53

  • 1周羡梅.假两性畸形的遗传致病基础[J].中国实用妇科与产科杂志,1995,11(1):19-20. 被引量:5
  • 2罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 3Hohenfellner R Norick A Fichtner J 陆曙炎译.泌尿外科手术创新与改良[M].上海科学技术出版社,2000.215~222.
  • 4Tajima T, Ma XM, Bornstein SR, et al. Prenatal dexamethasone treatment dose not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21 - hydroxylase deficient mice [ J ]. Endocrinology, 1999, 140 (7) :3354 -3362.
  • 5Merke DP, Cutler GB. New ideas for medical treatment of congenital adrenal hyperplasia [ J ]. Endocrinol Metab Clin North Am, 2001, 30 ( 1 ) : 121 - 135.
  • 6Nguyen An TT, Brown J J, Warne GL. Growth in congenital hyperplasia [ J ]. Indian J Pediatr,2006,73 ( 1 ) : 89 - 94.
  • 7孙文鑫,王伟,陆文丽,等.21-羟化酶缺乏症85例随访分析[C].第9届全国儿科内分泌、遗传代谢病学术会议资料汇编,2007,11:63.
  • 8Manoli I. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: Factors influencing the outcome [ J]. Clin Endocrinol, 2002,57 ( 5 ) : 669 - 676.
  • 9Savage MO, Lebrethon MC, Blair JC, et al. Growth abnormalities associated with adrenal disorders and their management [ J]. Horm Res, 2001, 56(supp 1) :19 -23.
  • 10Savage MO, Seommegna S, Carroll PV, et al. Growth in disorders of adrenal hyperfunction [ J]. Horm Res ,2002,58 ( supp 1 ) :39 - 43.

共引文献83

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部